Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
- 1 March 2010
- Vol. 46 (3) , 666-672
- https://doi.org/10.1016/j.bone.2009.11.011
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01AR041325, 5R01AR047838, 5T32AR007581, P30AR046121)
- Research Facilities Improvement Program (C06RR10601, C06-RR12538-01)
This publication has 64 references indexed in Scilit:
- Spatial Variation in Osteonal Bone Properties Relative to Tissue and Animal AgeJournal of Bone and Mineral Research, 2009
- Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronateOsteoporosis International, 2008
- Spectroscopic markers of bone quality in alendronate-treated postmenopausal womenOsteoporosis International, 2008
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Risks and benefits of bisphosphonatesBritish Journal of Cancer, 2008
- Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolutionin vitroJournal of Biomedical Materials Research Part A, 2007
- The role of cortical bone and its microstructure in bone strengthAge and Ageing, 2006
- The role of collagen in bone strengthOsteoporosis International, 2005
- Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog VertebraJournal of Bone and Mineral Research, 2003
- A 20-Year Perspective on the Mechanical Properties of Trabecular BoneJournal of Biomechanical Engineering, 1993